In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Gov. Gavin Newsom’s latest wiffle-waffle messaging on Israel is the Democratic Party’s problem in a nutshell: Even while support for the Palestinian people is now at a two-decade high, party ...